142280 — Green Cross Medical Science Share Price
Last trade - 00:00- KR₩82bn
- KR₩101bn
- KR₩104bn
- 42
- 22
- 17
- 13
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.01 | ||
| Price to Tang. Book | 2.05 | ||
| Price to Free Cashflow | 186.48 | ||
| Price to Sales | 0.8 | ||
| EV to EBITDA | 18.94 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.14% | ||
| Return on Equity | 9.46% | ||
| Operating Margin | 1.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 113,377.49 | 101,674.78 | 113,109.12 | 94,010.68 | 103,852.29 | n/a | n/a | 1.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -25.04 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Green Cross Medical Science Corporation is a Korea-based company principally engaged in the medical business. The Company mainly operates its business through three segments: diagnosis reagent segment, blood bag segment and blood dialysate segment. Its diagnosis reagent segment provides in vitro diagnosis reagents and medical equipment. Its blood bag segment provides filter bags and blood bags. The Company distributes its products within domestic market and to overseas markets.
Directors
- Yeong Pil Kim CEO (55)
- Seung Eul Baek OTH (52)
- Sang Sun Hwang OTH (60)
- Yeong Seok Park OTH (51)
- Jong Rak Choi NID (51)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 29th, 2003
- Public Since
- December 17th, 2014
- No. of Shareholders
- 22,628
- No. of Employees
- 175
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 21,706,926
- Address
- GCMS, YONGIN, 16924
- Web
- http://www.greencrossms.com/
- Phone
- +82 312609300
- Auditors
- KPMG Samjong Accounting Corp
Upcoming Events for 142280
Similar to 142280
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 20:56 UTC, shares in Green Cross Medical Science are trading at KR₩3,825. This share price information is delayed by 15 minutes.
Shares in Green Cross Medical Science last closed at KR₩3,825 and the price had moved by -6.82% over the past 365 days. In terms of relative price strength the Green Cross Medical Science share price has underperformed the FTSE Developed Asia Pacific Index by -5.76% over the past year.
There is no consensus recommendation for this security.
Find out moreGreen Cross Medical Science does not currently pay a dividend.
Green Cross Medical Science does not currently pay a dividend.
Green Cross Medical Science does not currently pay a dividend.
To buy shares in Green Cross Medical Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩3,825, shares in Green Cross Medical Science had a market capitalisation of KR₩82bn.
Here are the trading details for Green Cross Medical Science:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 142280
Based on an overall assessment of its quality, value and momentum Green Cross Medical Science is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Green Cross Medical Science. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +1.71%.
As of the last closing price of KR₩3,825, shares in Green Cross Medical Science were trading -4.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Green Cross Medical Science PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,825.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Green Cross Medical Science's management team is headed by:
- Yeong Pil Kim - CEO
- Seung Eul Baek - OTH
- Sang Sun Hwang - OTH
- Yeong Seok Park - OTH
- Jong Rak Choi - NID